CAPORASO, NICOLA
 Distribuzione geografica
Continente #
AS - Asia 7.989
EU - Europa 6.676
NA - Nord America 6.621
SA - Sud America 1.258
AF - Africa 189
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 9
Totale 22.752
Nazione #
US - Stati Uniti d'America 6.312
SG - Singapore 4.780
RU - Federazione Russa 3.056
CN - Cina 1.436
IT - Italia 1.406
BR - Brasile 1.090
HK - Hong Kong 841
VN - Vietnam 516
SE - Svezia 392
FI - Finlandia 360
DE - Germania 323
UA - Ucraina 313
NL - Olanda 265
CA - Canada 192
GB - Regno Unito 170
IE - Irlanda 126
IN - India 88
MX - Messico 71
AR - Argentina 70
FR - Francia 63
BD - Bangladesh 54
PL - Polonia 54
CI - Costa d'Avorio 52
ZA - Sudafrica 49
TR - Turchia 41
JP - Giappone 40
AT - Austria 34
ID - Indonesia 31
IQ - Iraq 30
ES - Italia 29
CO - Colombia 22
LT - Lituania 20
EC - Ecuador 19
MA - Marocco 17
VE - Venezuela 17
UZ - Uzbekistan 15
PY - Paraguay 14
KE - Kenya 12
AE - Emirati Arabi Uniti 11
CL - Cile 10
BE - Belgio 9
IR - Iran 9
KG - Kirghizistan 9
AZ - Azerbaigian 8
DO - Repubblica Dominicana 8
EG - Egitto 7
JM - Giamaica 7
JO - Giordania 7
PE - Perù 7
PS - Palestinian Territory 7
AU - Australia 6
DZ - Algeria 6
ET - Etiopia 6
NP - Nepal 6
RS - Serbia 6
SA - Arabia Saudita 6
TW - Taiwan 6
CH - Svizzera 5
IL - Israele 5
PA - Panama 5
RO - Romania 5
BO - Bolivia 4
CZ - Repubblica Ceca 4
EU - Europa 4
GR - Grecia 4
HN - Honduras 4
HU - Ungheria 4
KZ - Kazakistan 4
NG - Nigeria 4
PK - Pakistan 4
PT - Portogallo 4
UY - Uruguay 4
XK - ???statistics.table.value.countryCode.XK??? 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BY - Bielorussia 3
BZ - Belize 3
GT - Guatemala 3
MM - Myanmar 3
MY - Malesia 3
SO - Somalia 3
SY - Repubblica araba siriana 3
AL - Albania 2
AM - Armenia 2
AO - Angola 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BS - Bahamas 2
BW - Botswana 2
CR - Costa Rica 2
CW - ???statistics.table.value.countryCode.CW??? 2
CY - Cipro 2
DJ - Gibuti 2
DM - Dominica 2
GA - Gabon 2
KH - Cambogia 2
LB - Libano 2
LV - Lettonia 2
LY - Libia 2
MD - Moldavia 2
Totale 22.692
Città #
Singapore 1.949
Hong Kong 839
Chandler 789
Moscow 748
Ashburn 407
Beijing 402
Jacksonville 346
Princeton 328
Millbury 320
Santa Clara 315
Boston 281
Nanjing 241
Los Angeles 226
Amsterdam 198
Ho Chi Minh City 174
Buffalo 152
Ottawa 113
Napoli 104
Nanchang 95
New York 95
Hanoi 92
Naples 92
Wilmington 92
São Paulo 88
Des Moines 77
The Dalles 76
Redondo Beach 72
Milan 68
Munich 67
Boardman 64
Dong Ket 64
Dallas 61
Hefei 58
Rome 53
Kronberg 52
Hebei 50
Seattle 48
Shenyang 47
Mexico City 43
Warsaw 42
San Jose 41
Rio de Janeiro 40
Chicago 39
Frankfurt am Main 39
Bologna 38
Tianjin 35
Tokyo 35
Kunming 33
Norwalk 33
Falls Church 32
Jiaxing 31
Changsha 29
Houston 29
Montreal 28
Toronto 28
Denver 27
London 27
Helsinki 26
Brooklyn 25
Poplar 25
Haiphong 24
Lawrence 23
Nuremberg 23
Stockholm 23
Turku 23
San Francisco 22
Belo Horizonte 21
Orem 21
Phoenix 21
Brescia 19
Da Nang 19
Dublin 19
Johannesburg 19
Salvador 18
Chennai 17
Atlanta 16
Shanghai 15
Curitiba 14
Orange 14
Vienna 14
Ankara 13
Brasília 13
Falkenstein 13
Hangzhou 13
Porto Alegre 13
Tashkent 13
Washington 13
Ann Arbor 12
Campinas 12
Redwood City 12
Contagem 11
Fortaleza 11
Guangzhou 11
Istanbul 11
Manchester 11
Palermo 11
Redmond 11
Baghdad 10
Bergamo 10
Düsseldorf 10
Totale 10.687
Nome #
Terapia dell'ECA HBV-correlata 924
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 158
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 142
A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients 130
Eradication of HCV in Renal Transplant Recipients and Its Effects on Quality of Life 130
Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis 129
Cross-sectional evaluation of transmural healing in patients with Crohn's disease on maintenance treatment with anti-TNF alpha agents 128
Augmented Endoscopy for Surveillance of Colonic Inflammatory Bowel Disease: Systematic Review with Network Meta-Analysis 125
Validity and reliability of the Italian version of the Chronic Liver Disease Questionnaire (CLDQ-I) for the assessment of health-related quality of life. 124
A Simple Noninvasive Score Based on Routine Parameters can Predict Liver Cirrhosis in Patients With Chronic Hepatitis C 121
Viral Outcome in Patients with Occult HBV Infection or HCV-Ab Positivity Treated for Lymphoma 121
Alfa-glutathione transferases in HCV-related chronic hepatitis: a new predictive index of response to inteferon therapy? 120
Efficacy of a "contact center-based communication" in optimizing the care of inflammatory bowel diseases 119
Beyond Irritable Bowel Syndrome: The Efficacy of the Low Fodmap Diet for Improving Symptoms in Inflammatory Bowel Diseases and Celiac Disease 119
Diagnostic Accuracy of Ultrasonography in the Detection of Postsurgical Recurrence in Crohn's Disease: A Systematic Review with Meta-analysis 117
Bowel Damage in Crohn's Disease: Direct Comparison of Ultrasonography-based and Magnetic Resonance-based Lemann Index 116
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows 115
Gluten-free diet does not influence the occurrence and the Th1/Th17-Th2 nature of immune-mediated diseases in patients with coeliac disease. 115
Prevalence and risk factors of HCV infection in a metropolitan area in southern Italy: Tail of a cohort infected in past decades 115
A multi-stage genome-wide association study ofbladder cancer identifies multiple susceptibility loci 114
Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins 114
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 112
The burden of anaemia in patients with inflammatory bowel diseases 111
Evidence for multipotent endodermal stem/progenitor cell populations in human gallbladder 110
Reactivation of hepatitis B or C in patients with IBD receiving immunosuppressive drugs. A multicentre study 109
Decaffeinated coffee consumption induces expression of tight junction proteins in high fat diet fed rats 109
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 109
"Il punto su:". L'ipertransaminasemia di ndd 108
Metabolic syndrome in patients with coeliac disease on a gluten-free diet 108
Combined endoscopic/sonographic-based risk matrix model for predicting one-year risk of surgery: A prospective observational study of a tertiary centre severe/refractory crohn's disease cohort 108
Beneficial effects of gluten free diet in potential coeliac disease in adult population 107
Chronic hepatitis C: Interferon retreatment of relapsers. A Meta-analysis of individual patient data. 106
One-year clinical outcomes with biologics in Crohn's disease: transmural healing compared with mucosal or no healing. 106
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 105
Decaffeinated Coffee Reduces Body Weight Gain in Rats Fed With a Hfd by Modulating Intestinal Gpr41 and CCK Expression 105
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 105
BIOCHEMICAL MARKERS OF OXIDATIVE STRESS IN PERIPHERAL LYMPHOCYTES OF PATIENTS WITH HCV-RELATED LIVER DESEASES. 104
Berberis aristata, elaeis guineensis and coffea canephora extracts modulate the insulin receptor expression and improve hepatic steatosis in NAFLD patients: A pilot clinical trial 104
Quality of life assessment in chronic liver disease. 103
Coffee and Intestinal Permeability in a Mice Model of Non-Alcoholic Fatty Liver Disease 103
Prevalence of and risk factors for HBV infection in a metropolitan Southern Italian area: Evidence for the effectiveness of universal Hepatitis B vaccination 103
Proton pump inhibitors as risk factor for metabolic syndrome and hepatic steatosis in coeliac disease patients on gluten-free diet 102
Erratum to: Proton pump inhibitors as risk factor for metabolic syndrome and hepatic steatosis in coeliac disease patients on gluten-free diet 102
Circulating SCCA–IgM complex is a useful biomarker to predict the outcome of therapy in hepatocellular carcinoma patients 102
Dietary supplementation of vitamin D prevents the development of western diet-induced metabolic, hepatic and cardiovascular abnormalities in rats 102
Therapy expectations and physical comorbidity affect quality of life in chronic hepatitis C virus infection. 101
Vitamin D levels and chronic hepatitis C 101
Profiles of cancer stem cell subpopulations in cholangiocarcinomas 101
An emerging issue in differential diagnosis of diarrhea: sprue-like enteropathy associated with olmesartan 101
Lack of evidence that adherence to standard of care therapy improves survival in subjects with hepatocellular carcinoma in clinical practice 100
Vitamin D-PTH axis in HCV infection 99
Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel 99
Metabolic disorders across hepatocellular carcinoma in Italy 99
Risk stratification of HCC occurrence after HCV eradication: a complicate plot of risk factors related and unrelated to the previous viral disease 99
Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study. 98
FRAX Score Can Be Used to Avoid Superfluous DXA Scans in Detecting Osteoporosis in Celiac Disease: Accuracy of the FRAX Score in Celiac Patients 98
Prevalence of HBcAg and delta-Ag in liver tissue of patients with HBsAg positive chronic hepatitis 97
Coffee and liver health 97
Coeliac disease in the elderly in a tertiary centre 97
The combination of berberine, tocotrienols and coffee extracts improves metabolic profile and liver steatosis by the modulation of gut microbiota and hepatic mir‐122 and mir‐34a expression in mice 97
Tamoxifen in treatment of hepatocellular carcinoma: a randomised controlled trial. 96
Timing strategies of direct-acting antivirals and biologics administration in HCV-infected subjects with inflammatory bowel diseases 96
Bowel sonography in predicting post-operative course of Crohn’s disease. 95
Decaffeinated coffee reduces gut leakiness in rats fed with high-fat diet. The role of Occludin and Zonulin-1 95
Decaffeinated Coffee Reduces Intestinal Leakiness in Rats Fed With a Hfd by Modulating Occludin and Zonulin-1 Expression 95
Skeletal muscle myopenia in mice model of bile duct ligation and carbon tetrachloride-induced liver cirrhosis 95
Bioavailability of trans-resveratrol from red wine in humans. 93
Il ruolo dell'ecografia intestinale nel predire il decorso clinico post-operatorio della malattia di Crohn 93
Apple polyphenols extract (APE) improves colon damage in a rat model of colitis 93
Effect of immunosuppressive therapy on patients with inflammatory bowel diseases and hepatitis B or C virus infection. 93
Spread of hepatitis C virus infection within families 92
AISF position paper on liver disease and pregnancy 92
Hepatitis-C virus infection in Italy: a multicentric sero-epidemiological study. (A report from the HCV study group of the Italian Association for the Study of the Liver) 91
Interactions between metabolic disorders (diabetes, gallstones, and dyslipidaemia) and the progression of chronic hepatitis C virus infection to cirrhosis and hepatocellular carcinoma. A cross-sectional multicentre survey. 91
Impact of Diabetes on Outcomes of Sorafenib Therapy for Hepatocellular Carcinoma 91
The role of TMPRSS6 and HFE variants in iron deficiency anemia in celiac disease 91
Incidence of HCC recurrence after DAA treatment for HCV in a multicentre Italian cohort study 91
Performance of the model for end-stage liver disease score for mortality prediction and the potential role of etiology 90
Garlic extract prevents CCl(4)-induced liver fibrosis in rats: The role of tissue transglutaminase. 90
Sustained virological response by direct antiviral agents in HCV leads to an early and significant improvement of liver fibrosis 90
HCV infection and hepatocellular carcinoma in cirrhotics: What is the linkage? 88
Interferon-related thyroid autoimmunity and long-term clinical outcome of chronic hepatitis C. 88
Parietal Healing in Patients With Crohn's Disease on Maintenance Treatment With Biologics 88
Osteoporosis across chronic liver disease 88
Incidence of site effects during therapy with different types of alpha interferon: a randomized controlled trial compared recombinant alpha 2-b versus leukocyte interferon in the therapy of naives patients with chronic hepatitis C 87
Systematic review: interferon-free regimens for patients with HCV-related Child C cirrhosis 86
Tomato-based Functional Food as Interferon Adjuvant in HCV Eradication Therapy 85
Clinical significance of immunoglobulin M antibody to hepatitis C virus core. 85
parathyroid hormone-vitamin d axis in patients with chronic hepatitis c 85
Hepatitis B and C virus reactivation in immunosuppressed patients with inflammatory bowel disease. 85
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) mimicking refractory celiac disease 84
Characteristic of liver cirrhosis in Italy: results from a multicenter national study 82
Foods and liver health 82
Lack of evidence of viral reactivation in HBsAg-negative HBcAb-positive and HCV patients undergoing immunosuppressive therapy for psoriasis. 82
Intrafamilial transmission of hepatitis delta virus: molecular evidence. 81
Psoriasis, Psoriatic Arthritis, or Psoriatic Disease? 81
ONLINE ANALYSIS OF BREATH BY PROTON TRANSFER REACTION TIME OF FLIGHT MASS SPECTROMETRY IN CIRRHOTIC PATIENTS 81
Noninvasive diagnosis of small bowel Crohn's disease: direct comparison of bowel sonography and magnetic resonance enterography. 80
Liver resection is always a good choice for hepatocellular carcinoma (HCC) patients regardless of Barcelona Clinic Liver Cancer (BCLC) stage: the therapeutic hierarchy 80
Dietary antioxidant compounds and liver health 79
Totale 10.953
Categoria #
all - tutte 78.772
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.772


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021436 0 0 0 0 0 0 69 5 115 56 111 80
2021/20221.527 50 7 12 12 5 30 27 56 137 61 271 859
2022/20231.980 385 115 46 184 250 214 10 201 273 202 77 23
2023/20241.207 46 176 94 62 40 98 56 145 19 33 288 150
2024/20257.484 464 631 42 73 176 224 731 412 979 724 2.342 686
2025/20267.545 1.579 818 1.255 1.030 2.257 562 44 0 0 0 0 0
Totale 23.050